Ishimori, Shingo http://orcid.org/0000-0003-3863-2743
Horinouchi, Tomoko
Fujimura, Junya
Yamamura, Tomohiko
Matsunoshita, Natsuki
Kamiyoshi, Naohiro
Sato, Mai
Ogura, Masao
Kamei, Koichi
Ishikura, Kenji
Iijima, Kazumoto
Nozu, Kandai
Article History
Received: 4 May 2022
Revised: 17 September 2022
Accepted: 10 October 2022
First Online: 30 November 2022
Declarations
:
: All procedures performed in this study involving human participants were in accordance with the ethical standards set by the Ethics Board at Kakogawa Central City Hospital in which the study was conducted (approval number 29–12) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Before enrollment, written informed consent was obtained from all patients and their parents for this study in accordance with guidelines.
: K.K. has received research funding from the Terumo Foundation for Life Sciences and Arts, Public Foundation of Vaccination Research Center, and Taiju Life Social Welfare Foundation; donations from Chugai Pharmaceutical Co. Ltd., Astellas Pharma Inc., Ono Pharmaceutical Co., Teijin Pharma Ltd. Shionogi Co. Ltd., and Otsuka Pharmaceutical Co. Ltd.; and lecture fees from Tanabe Mitsubishi Pharma, Baxter Ltd., and Zenyaku Kogyo Co. Ltd. K. Ii. reports consultancy agreements with Zenyaku Kogyo Co. Ltd., Ono Pharmaceutical Co. Ltd., Kyowa Kirin Co. Ltd., JCR Pharmaceuticals Co. Ltd., Takeda Pharmaceutical Co. Ltd. and Sanofi K.K.; research funding from Zenyaku Kogyo Co. Ltd., Astellas Pharma Inc., Air Water Medical Inc., Otsuka Pharmaceutical Co. Ltd., Mochida Pharmaceutical Co. Ltd., Eisai Co. Ltd., Shionogi Co. Ltd., JCR Pharmaceuticals Co. Ltd. and Nihon Pharmaceutical Co. Ltd.; honoraria from Chugai Pharmaceutical Co. Ltd., Zenyaku Kogyo Co. Ltd., Kyowa Kirin Co. Ltd., Integrated Development Associates Co. Ltd., Astellas Pharma Inc. and Shionogi Co. Ltd.; a patent application on the development of antisense nucleotides for exon skipping therapy in Alport syndrome with Daiichi Sankyo Co. Ltd.; scientific advisor or membership as a member of editorial board of Pediatric Nephrology and Clinical Journal of the American Society of Nephrology.
Free to read: This content has been made available to all.